Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

By  

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 211-213

Informa Healthcare

Access to resources Recommend Favorite

ABCG2 gene amplification and expression in esophageal cancer cells with acquired adriamycin resistance

By      

Molecular Medicine Reports, Vol. 9, Iss. 4, 2014-01 ,pp. : 1299-1304

Spandidos Publications

Access to resources Recommend Favorite

Gene expression profiling of breast cancer cells in response to gemcitabine: NF-B pathway activation as a potential mechanism of resistance

By Hernández-Vargas Héctor   Rodríguez-Pinilla Socorro   Julián-Tendero Mercedes   Sánchez-Rovira Pedro   Cuevas Cristóbal   Antón Antonio   Ríos Maria   Palacios José  

Breast Cancer Research and Treatment, Vol. 102, Iss. 2, 2007-04 ,pp. : 157-172

Springer Publishing Company

Access to resources Recommend Favorite

E2F1 Expression is Related with the Poor Survival of Lymph Node-positive Breast Cancer Patients Treated with Fluorouracil, Doxorubicin and Cyclophosphamide

By Han Sehwan  

Breast Cancer Research and Treatment, Vol. 82, Iss. 1, 2003-01 ,pp. : 11-16

Springer Publishing Company

Access to resources Recommend Favorite

Expression of the multidrug resistance gene in human prostate cancer

By Bhangal G.   Halford S.   Wang J.   Roylance R.   Shah R.   Waxman J.  

Urologic Oncology: Seminars and Original Investigations, Vol. 5, Iss. 3, 2000-04 ,pp. : 118-121

Elsevier

Access to resources Recommend Favorite